NYSEMKT: VNRXVolitionrx Ltd Stock Ownership - Who owns Volitionrx?
Insider buying vs selling
Have Volitionrx Ltd insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Phillip Barnes | Director | 2023-09-05 | 5,000 | $1.30 | $6.50kBuy |
| Martin Charles Faulkes | Director | 2023-08-31 | 9,716 | $1.28 | $12.44kBuy |
| Mickie Henshall | Director | 2023-08-31 | 3,706 | $1.25 | $4.63kBuy |
| Jacob Vincent Micallef | Chief Scientific Officer | 2023-08-30 | 8,750 | $1.27 | $11.11kBuy |
| Jacob Vincent Micallef | Chief Scientific Officer | 2023-08-29 | 11,250 | $1.24 | $13.95kBuy |
| Jacob Vincent Micallef | Chief Scientific Officer | 2023-08-25 | 20,000 | $1.24 | $24.80kBuy |
| Jasmine Kway | CEO - Singapore Volition | 2023-08-24 | 5,000 | $1.20 | $6.00kBuy |
| Edward Futcher | Director | 2023-08-24 | 5,000 | $1.22 | $6.10kBuy |
| Gaetan Michel | Chief Operating Officer | 2023-08-24 | 5,000 | $1.23 | $6.15kBuy |
| Salvatore Thomas Butera | CEO - Volition Veterinary | 2023-08-16 | 8,000 | $1.21 | $9.68kBuy |
VNRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when VNRX insiders and whales buy or sell their stock.
VNRX Shareholders
What type of owners hold Volitionrx Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Eight Corp Ltd | 15.42% | 12,045,332 | $8.30M | Insider |
| Cameron John Reynolds | 9.77% | 7,632,000 | $5.26M | Insider |
| Rodney Gerard Rootsaert | 5.28% | 4,126,176 | $2.84M | Insider |
| Lagoda Investment Management LP | 5.03% | 3,929,110 | $2.71M | Institution |
| Guy Archibald Innes | 4.36% | 3,403,569 | $2.35M | Insider |
| Martin Charles Faulkes | 2.60% | 2,029,532 | $1.40M | Insider |
| Edward Futcher | 0.99% | 774,936 | $533.93k | Insider |
| Blackrock Inc | 0.73% | 568,026 | $391.37k | Institution |
| Vanguard Group Inc | 0.67% | 520,398 | $358.55k | Institution |
| Geode Capital Management LLC | 0.60% | 465,214 | $320.53k | Institution |
VNRX vs Diagnostic & Research Stocks
Volitionrx Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.